Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
NZSG Train the Colonoscopy Trainer Course
Saturday March 7, 2026
Building the Next Generation of Colonoscopy Trainers
NZSG Introduction to Endoscopy Course
Saturday March 7, 2026
Our February Course was a great success, and August is looking to be another full course.
Survey for clinicians who care for people with bowel cancer and/or IBD
Saturday March 7, 2026
This study aims to understand current perioperative information practices, identify perceived gaps, and explore regional...